Welcome to FOOON a REVITALIZE by PK brand (www.thefooon.com), where innovation fuels holistic wellness. We craft products across Nous (Brain), Soma (Body), and Hypnos (Sleep) to elevate your daily well-being. Dive into a world where thoughtful design, quality, and science converge to bring you products that inspire brighter thinking, balanced living, and deeper sleep. Think Bright, Feel Right, Sleep Tight with FOOON

Study Design Lead - Clinical Database DesignerReviewing pharmaceutical companies’ clinical protocols, defining the components of clinical trial study designs, and working with internal teams to highlight risks and financial impacts associated with various study design options. Translate all documented customer expectations in Labcorp database in order to provide seamless services• Interpreting clinical protocol requirements and coordinating the preparation of Labcorp clinical trial databases and Statement of Work documents (SOW)• Utilizing technical, therapeutic area, and pharmaceutical industry knowledge to successfully coordinate the completion of Labcorp clinical trial databases• Coordinating internal processes and communications related to study design, ensuring that follow-up actions are recorded, and global monitoring plans are implemented• Ensuring that all customer requirements are documented and acted upon• Building strong client relationships to ensure high quality study design• Manage and solve technical changes, issues and concerns• Manage day-to-day project loading related activities• Review the clinical protocol and make appropriate technical recommendations

• Designed the project and assessed the HRA forms on IRAS for approvals• Consented patients for clinical studies• Managed all admin, blood/plasma samples and group of students/researchers/nurses• Analyzed results, wrote scientific reports/articles/postersKey projects: ‘Detection of CTCs and ctDNA in Lung Cancer and Mesothelioma patients’, ‘The effect of the anesthetic agent during lung cancer surgery in clinical outcome’,‘Digital pathology in lung/mesothelioma cancer patients underwent surgery in RBHH trust’

• Processed/analyzed clinical samples for >200 patients (CICATRIx study) • Analyzed results and wrote scientific reports/articles/posters • Trained students/researchers for the data/sample collection/analysis and Good Laboratory Practice (GLP), documented SOPs and COSHH, managed stock/orders/budgetKey project: ‘Liquid biopsies in Lung, Ovarian, Prostate cancer, and Mesothelioma patients’

Laboratory demonstrator for UG and MSc practical sessions in the Brunel Biosciences department• Demonstration of practical laboratory techniques for undergraduate students (groups of 50)• Lesson planning and marking undergraduate practical exams, oral and poster presentations

Use of liquid Biopsies as diagnostic and prognostic biomarkers for Lung Cancer. Circulating tumor cells (CTCs) enumeration and characterizasion, Circulating tumor DNA (ctDNA) quantification and mutation detection, LncRNA XIST functional analysis in lung cancer

• Processed/analyzed clinical samples for >200 patients (CICATRIx study) • Analyzed results and wrote scientific reports/articles/posters

Project: Electrochemotherapy of uveal and conjunctival melanoma cells in 2D/3D cell culturesCultured Uveal and Conjunctival primary cell lines, optimized culture techniques, established 3D culture protocols, examined the effect of electrochemotherapy with 4 agents, conducted IHC, microscopy and imagingSupervisor: Sarah E Coupland

Deregulation of folate pathway genes in Non-Small Cell Lung Cancer‘Investigation of the role of CBS and SHMT genes in DNA methylation and resistance to antifolates Methotrexate, 5-Fluorouracil and Pemetrexed in Lung Cancer’ -Cultured 13 NSCLC and Head & Neck Cancer cell lines, DNA/RNA extraction from cell lines and 100 Normal-Tumor patient samples, Pyrosequencing for LINE-1 methylation, cloning, established stable cell lines with inducible promoters, calibrated Applied Biosystems Instruments, Pyrosequencing and STR profilingSupervisor: Dr. Lakis Liloglou, Dr. John Field

Identification of new biomarkers for lung and head and neck cancer

Processed and analyzed samples for blood and urine tests in hospital laboratory ( ̴ 1000/day)